Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipoprotein-apheresis”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Large-scale testing (Phase 3)Study completedNCT02585895
What this trial is testing

Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment

Who this might be right for
Hypercholesterolemia
Amgen 39
Large-scale testing (Phase 3)Study completedNCT02326220
What this trial is testing

Study of Alirocumab (REGN727/SAR236553) in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Undergoing Low-density Lipoprotein (LDL) Apheresis Therapy

Who this might be right for
Heterozygous Familial Hypercholesterolemia
Regeneron Pharmaceuticals 62
Large-scale testing (Phase 3)Active Not RecruitingNCT05900141
What this trial is testing

An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Who this might be right for
Hyperlipoproteinemia (a)
Novartis Pharmaceuticals 41
Not applicableStudy completedNCT07390604
What this trial is testing

Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patients With Chronic Kidney Disease ; ( LiPo-A )

Who this might be right for
Lipoprotein(a)Lipoprotein-apheresisDouble-filtration Plasmapheresis+2 more
Centre Hospitalier Régional Metz-Thionville 5
Not applicableStudy completedNCT01796912
What this trial is testing

Lipoprotein Apheresis in Refractory Angina Study

Who this might be right for
Refractory AnginaRaised Lipoprotein(a)>50mg/dL or >500mg/L
Imperial College London 20
Not applicableUnknownNCT05181969
What this trial is testing

Long-term Characterization of Lipoprotein Apheresis Technologies for Individual Device Adaption (LOLIDA)

Who this might be right for
LipoproteinemiaApheresis Related ComplicationCardiovascular Diseases
Technische Universität Dresden 500
Large-scale testing (Phase 3)Study completedNCT05305664
What this trial is testing

Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of Weekly Lipoprotein Apheresis Sessions in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease in Germany

Who this might be right for
Hyperlipoproteinemia(a)
Novartis Pharmaceuticals 51
Not applicableUnknownNCT02791802
What this trial is testing

Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular Outcomes

Who this might be right for
Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia
Technische Universität Dresden 1,000
Not applicableStudy completedNCT02286596
What this trial is testing

Comparisons of Two Low-density Lipoprotein Apheresis Systems in Patients With Homozygous Familial Hypercholesterolemia

Who this might be right for
Homozygous Familial Hypercholesterolemia
Laval University 9
Large-scale testing (Phase 3)Study completedNCT02133807
What this trial is testing

Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis

Who this might be right for
AtherosclerosisCoronary DiseaseCarotid Artery Diseases
Russian Cardiology Research and Production Center 32
Post-approval studies (Phase 4)Study completedNCT00916643
What this trial is testing

Low-Density Lipoprotein (LDL) Apheresis Using H.E.L.P. Therapy

Who this might be right for
Familial Hypercholesterolemia
B. Braun Medical Inc. 113
Not applicableStudy completedNCT01138371
What this trial is testing

Effects of Low-density Lipoprotein (LDL) Apheresis on Inflammatory and Lipid Markers

Who this might be right for
Familial Hypercholesterolemia
Emory University 8
Not applicableWithdrawnNCT01064934
What this trial is testing

Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a)

Who this might be right for
Hyperlipoproteinemia(a)Progressive Cardiovascular Disease
Charite University, Berlin, Germany
Not applicableStudy completedNCT02462655
What this trial is testing

Effects of LDL Apheresis System on the Expression of Genes Involved in Lipoprotein Metabolism and Inflammation in Homozygotes for Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia
Laval University 9
Not applicableStudy completedNCT00526058
What this trial is testing

(H.E.L.P.)Apheresis Therapy to Compare the Reduction of LDL (Low Density Lipoprotein) Cholesterol

Who this might be right for
Hypercholesterolemia
B. Braun Medical Inc. 18
Not applicableStudy completedNCT03795038
What this trial is testing

Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI

Who this might be right for
Hypercholesterolemia, FamilialDyslipidemiasCardiovascular Diseases
Fresenius Medical Care Deutschland GmbH 20